The Basal Ganglia III

Front Matter....Pages i-xviii
Front Matter....Pages 1-1
Striosomes and Matrisomes....Pages 3-12
The Development of Striatal Compartmentalization: The Role of Mitotic and Postmitotic Events....Pages 13-20
Correlated Light and Electron Microscopy of Golgi-Impregnated Neostriatal Neurons after 6-Hydroxydopamine Lesions in the Rat....Pages 21-28
Coexpression of Neuropeptides and Glutamic Acid Decarboxylase in Cat Striatal Neurons: Dependence Striosomal Compartmentation....Pages 29-38
Organization of Cholinergic Perikarya in the Caudate Nucleus of the Cat with Respect to Heterogeneities in Enkephalin and Substance P Staining....Pages 39-48
Neuropeptide Y Neurons in the Striatal Network. Functional Adaptive Responses to Impairment of Striatal Inputs....Pages 49-61
Topographical Organization of the Thalamostriatal Projection in the Japanese Monkey, Macaca Fuscata , with Special Reference to the Centromedian-Parafascicular and Motor Thalamic Nuclei....Pages 63-72
Complementarity of the Two Pallidal Segments in the Primate....Pages 73-79
The Pallidum as a Dual Structure in Primates....Pages 81-88
The Connections of the Medial Part of the Subthalamic Nucleus in the Rat: Evidence for a Parallel Organization....Pages 89-98
The Subthalamic Nucleus: New Data, New Questions....Pages 99-108
Subthalamic Nucleus Afferents: Anatomical and Immunocytochemical Features....Pages 109-117
Characterization of the Synaptic Inputs to Dopaminergic Neurones in the Rat Substantia Nigra....Pages 119-131
Multi-Collateralization of the Dopaminergic Nigrotectal Projection in the Rat....Pages 133-142
Convergent Projections from Substantia Nigra and Cerebellum on Pontine Reticular Formation of Rat....Pages 143-155
Involvement of the Nucleus Tegmenti Pedunculopontinus in the Descending Pathways of the Basal Ganglia in the Rat....Pages 157-165
Synaptic Organization of Nucleus Accumbens (Ventral Striatum)....Pages 167-176
The Primate Central Complex as One of the Basal Ganglia....Pages 177-186
The Ultrastructural Chemoanatomy of the Basal Ganglia: 1984–1989. I. The Neostriatum....Pages 187-197
The Ultrastructural Chemoanatomy of the Basal Ganglia: 1984–1989. II. The Pallidum, Substantia Nigra and Subthalamic Nucleus....Pages 199-209
Front Matter....Pages 211-211
Dye-Coupling in the Neostriatum of the Rat....Pages 213-220
Neurophysiological Changes in Aged Striatal Neurons in Rats....Pages 221-229
Short-Term Plasticity in the Ventral Striatum a Comparision between in Vivo and in Vitro Measurements....Pages 231-237
Spontaneous Depolarizing Synaptic Potentials in the Neostriatum....Pages 239-247
Dopamine D1 Receptors and Terminal Excitability in the Striatonigral and Nigrostriatal Systems....Pages 249-258
In Vivo Development of the Spontaneous Activity of Rat Nigrostriatal Dopaminergic Neurons....Pages 259-268
Characterization of GABA and Glycine Actions on Substantia Nigra Zona Compacta Neurons....Pages 269-273
Cholinergic Excitation of A9 and A10 Dopaminergic Neurones in Vitro through Both Nicotinic and Muscarinic Receptors....Pages 275-284
Inward Rectifying Properties of Nucleus Accumbens Neurones in Vitro....Pages 285-291
The Glutamatergic and Gabaergic Transmitter System in the Rat Nucleus Accumbens: An Electrophysiological in Vitro Study....Pages 293-301
A Comparison of Single Unit Activity in Primate Caudate Nucleus and Putamen in a Sensory Cued Motor Task....Pages 303-310
Front Matter....Pages 311-311
Comparative Distribution of D1 Receptors and μ Opiate Receptors in the Neonatal Rat Striatum: Effects of an Early Lesion of Dopaminergic Fibers....Pages 313-320
Dopaminergic and Muscareinc Cholinergic Receptor Subtype: Localization to Neurotransmitters Specific Components of the Striatum....Pages 321-333
Pharmacological and Morphological Properties of Two Functionally Distinct Subpopulations of Striatal Neurons....Pages 335-345
Influence of Cortico-Striatal Glutamatergic Neurons on Dopaminergic Transmission in the Striatum....Pages 347-355
Modulation of Striatal Dopamine and Acetylcholine Release by Different Glutamate Receptors: Studies with in Vivo Microdialysis....Pages 357-362
Distinct Cholinergic Control of Dopamine Release in Striosomal and Matrix Areas of the Cat Caudate Nucleus....Pages 363-370
Effect of Neurotensin on Dopamine and Muscarinic Acetylcholine Receptors in the Rat Striatum....Pages 371-378
Regulation of NT Receptors after Chronic Treatment with Typical and Atypical Neuroleptic Drugs....Pages 379-387
Evidence for D2-Dopamine Receptors Modulating Noradrenaline Release in the Rat Frontal Cortex....Pages 389-395
Front Matter....Pages 311-311
Comparative Investigations of Terguride Isomers on Central Dopamine and Noradrenaline Functions....Pages 397-406
Specifically Evoked Release of Newly Synthesized or Stored Dopamine by Different Treatments....Pages 407-416
Interactions between D1 and D2 Dopamine Receptor Mechanisms: The Immediate Early Response Gene C-Fos in Long-Term Changes in the Striatum....Pages 417-423
Inhibitory Role of Dopaminergic D2 Receptors in the Expression of Glutamic Acid Decarboxylase and Preproenkephalin mRNA in the Rat Striatum....Pages 425-432
Modulation of Gene Expression by Neuronal Lesions in the Rat Striatum....Pages 433-441
Priming of the Behavioral Expression of Dopamine-Receptor Supersensitivity in the Basal Ganglia: Pharmacological and Biochemical Studies....Pages 443-452
Front Matter....Pages 453-453
Behavioral Effects of Single and Repeated Treatments with the Combination of D1 and D2 Antagonists....Pages 455-462
Responses of Motor- and Nonmotor-Related Neostriatal Neurons to Amphetamine and Neuroleptic Drugs....Pages 463-470
The Role of the Dorsal and Ventral Striatum in the Therapeutic and Extrapyramidal Side Effects of Neuroleptic Drugs....Pages 471-479
Interaction of EAA- and GABA-Neurotransmission in the SNR of Cats: Open Field Behaviour....Pages 481-485
Responses of Monkey Dopamine Neurons to External Stimuli: Changes with Learning....Pages 487-494
The Basal Ganglia: A Role in Mediation of Motor Equivalence....Pages 495-497
Front Matter....Pages 499-499
The Importance of MPP + Localization for the Manifestation of MPTP-Induced Neurotoxicity....Pages 501-510
Methamphetamine and MPTP: Similarities and Differences in Mechanisms of Neurotoxic Action....Pages 511-517
Retrograde Axonal Transport of MPTP after Unilateral Caudate Nucleus Infusion in the Monkey....Pages 519-522
Chronic Administration of 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine to Marmosets....Pages 523-531
L-DOPA-Induced Chorea and Dystonia in MPTP-Treated Squirrel Monkeys....Pages 533-539
Electrophysiological Study of Dyskinesia Produced by Microinjection of Picrotoxin into the Striatum of the Rat....Pages 541-549
Neurophysiological Development of Fetal Neostriatal Neurons Transplanted into Adult Neostriatum....Pages 551-560
A Primate Model of Huntington’s Disease: Unilateral Striatal Lesions and Neural Grafting in the Baboon (Papio papio)....Pages 561-572
Front Matter....Pages 499-499
[14C]-2-Deoxyglucose Autoradiographic Studies of Dopaminergic Drugs in an Animal Model of Parkinson’s Disease....Pages 573-579
Effects of Transient Global Ischemia on the Basal Ganglia of Rat....Pages 581-590
Role of D1 and D2 Dopamine Receptors in Pilocarpine-Induced Seizures....Pages 591-596
Dopaminergic Dysfunctions in Neonatal Hypothyroidism....Pages 597-606
Advances in the Understanding of Neural Mechanisms in Movement Disorders....Pages 607-616
Front Matter....Pages 617-617
Neuropeptide mRNA Expression in Human Basal Ganglia....Pages 619-628
Neuropeptides Receptors Changes in Huntington’s Chorea Basal Ganglia are Unrelated to Changes in Neuropeptides Levels....Pages 629-635
Neural Activity of the Basal Ganglia in Parkinson’s Disease Studied by Depth Recording and Pet Scan....Pages 637-644
Differential Aspects of Parkinsonian Akinesia as Revealed by Limb Movement Studies....Pages 645-652
Retinal Visual Dysfunction, in Parkinson’s Disease, is Enhanced by Low Contrast Stimuli....Pages 653-661
Rapid Eye Movements During Stage REM are Modulated by Nigrostriatal Dopamine Neurons?....Pages 663-671
 In Vivo Neurochemical Analyses of Exogenously Administered L-DOPA: Implications for Treatment of Parkinson’s Disease....Pages 673-682
The Pharmacokinetics of L-DOPA in Plasma and CSF of the Monkey....Pages 683-688
Treatment of Motor Fluctuations in Parkinson’s Disease: Controlled Release Preparations....Pages 689-695
Course of Motor and Cognitive Impairment in Huntington’s Chorea....Pages 697-701
Impairment of the Cognitive Functions in Parkinson’s Disease: A Brief Survey....Pages 703-715
Environmental Risk Factors in Parkinson’s Disease....Pages 717-722
New Therapeutic Strategies in Parkinson’s Disease: Inhibition of MAO-B by Ro 19-6327 and of COMT by Ro 40-7592....Pages 723-732
Clinical and Neuroendocrinological Effects of Estrogens in Postmenopausal Women with Parkinson’s Disease....Pages 733-741
Vision and Visual Discrimination Suffer in Parkinson’s Disease: Evoked Potential Evidence....Pages 743-750
Back Matter....Pages 751-775